To determine the efficacy of combined inhibition of guanine nucleotide biosynthesis and menin in vivo, we first evaluated the efficacy of a menin inhibitor ziftomenib in mice transplanted with murine MLL-AF9-induced AML. Here, MLLT3 is linked to acute myeloid leukemia.